{"version":"1.0","provider_name":"Press Arabia","provider_url":"https:\/\/pressarabia.qa","author_name":"admin","author_url":"https:\/\/pressarabia.qa\/author\/admin01\/","title":"Medical Metaverse Company, apoQlar, Receives FDA 510(k) Clearance for its Mixed Reality Surgical Planning Platform, VSI HoloMedicine\u00ae - Press Arabia","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"bpnMuoUwvd\"><a href=\"https:\/\/pressarabia.qa\/medical-metaverse-company-apoqlar-receives-fda-510k-clearance-for-its-mixed-reality-surgical-planning-platform-vsi-holomedicine\/\">Medical Metaverse Company, apoQlar, Receives FDA 510(k) Clearance for its Mixed Reality Surgical Planning Platform, VSI HoloMedicine\u00ae<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/pressarabia.qa\/medical-metaverse-company-apoqlar-receives-fda-510k-clearance-for-its-mixed-reality-surgical-planning-platform-vsi-holomedicine\/embed\/#?secret=bpnMuoUwvd\" width=\"600\" height=\"338\" title=\"&#8220;Medical Metaverse Company, apoQlar, Receives FDA 510(k) Clearance for its Mixed Reality Surgical Planning Platform, VSI HoloMedicine\u00ae&#8221; &#8212; Press Arabia\" data-secret=\"bpnMuoUwvd\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"HAMBURG, Germany, Dec. 5, 2022 \/PRNewswire\/ \u2014 apoQlar, a German medical technology company, today announced it has received FDA 510(k) Class II clearance for VSI HoloMedicine\u00ae, a pioneering mixed reality software device enabling surgeons to plan complex procedures using the power of immersive 3D holographic technology. With this clearance, the USA becomes the 30th country [\u2026]","thumbnail_url":"https:\/\/ci6.googleusercontent.com\/proxy\/7y57VcRG6m-dmmHkyZx1Z9OEGjaWK5bxAOhXncFOTJIcXoSd7C8_kzGbNpYeYj8SSRg-AZ0l-__2_TRCE63ZhAi-MeMgbi5D14qHnr5wV7nHwG1B=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/1959036\/apoQlar_3D_holograms.jpg"}